Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 29, 2015 2:47 PM ET


Company Overview of Ember Therapeutics, Inc.

Executive Profile

Jeffrey Saunders Ph.D.

Vice President of Small Molecule Drug Discovery, Ember Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 3 different industries.

See Board Relationships


Dr. Jeffrey Saunders, also known as Jeff, Ph.D has been Vice President of Small Molecule Drug Discovery at Ember Therapeutics, Inc. since May 2012. Dr. Saunders served as Head/Vice president of Chemistry at Agios Pharmaceuticals Inc. from 2007 to May 2012. Prior to Agios, Dr. Saunders worked as a consultant at Elixir Pharmaceuticals Inc., where he managed all chemistry and related intellectual property for 5 years, and as a consultant for Agios for one and a half years. ...

Corporate Headquarters

29 Newbury Street
Boston, Massachusetts 02116

United States

Phone: 617-585-2000
Fax: --

Board Members Memberships

There is no Board Members Memberships data available.


University of South Carolina
Hope College

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Ember Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at